4.85 0.35 (7.78%) | 02-14 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 6.42 ![]() |
1-year : | 7.5 ![]() |
Resists | First : | 5.5 ![]() |
Second : | 6.42 ![]() |
Pivot price | 4.64 ![]() |
|||
Supports | First : | 4.51 ![]() |
Second : | 3.9 ![]() |
MAs | MA(5) : | 4.75 ![]() |
MA(20) : | 4.63 ![]() |
MA(100) : | 3.72 ![]() |
MA(250) : | 4.67 ![]() |
|
MACD | MACD : | 0.1 ![]() |
Signal : | 0.1 ![]() |
%K %D | K(14,3) : | 43.7 ![]() |
D(3) : | 47 ![]() |
RSI | RSI(14): 57.7 ![]() |
|||
52-week | High : | 8.82 | Low : | 2.7 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ XYLO ] has closed below upper band by 28.8%. Bollinger Bands are 6.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 4.88 - 4.9 | 4.9 - 4.92 |
Low: | 4.55 - 4.57 | 4.57 - 4.59 |
Close: | 4.81 - 4.85 | 4.85 - 4.88 |
Tue, 04 Feb 2025
Xylo Technologies: Revoltz Receives Israeli Standards Institute Approval for PORTO EV Micro Vehicle - GlobeNewswire
Tue, 04 Feb 2025
Xylo Technologies Gains Israeli Approval for PORTO EV - MSN
Tue, 04 Feb 2025
Xylo Technologies Gains Israeli Approval for PORTO EV - TipRanks
Tue, 04 Feb 2025
Israeli Standards Institute Greenlights Revolutionary Last-Mile EV: 16-Year-Olds Can Drive Without License - StockTitan
Thu, 15 Aug 2024
Xylo Technologies: ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems - GlobeNewswire
Tue, 30 Jul 2024
Xylo Technologies Announces Plan to Implement ADS Ratio Change - GlobeNewswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Specialties
|
|
Shares Out | 1 (M) |
Shares Float | 29 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0.8 (%) |
Shares Short | 4 (K) |
Shares Short P.Month | 5 (K) |
EPS | -23.21 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 21.06 |
Profit Margin | -27.8 % |
Operating Margin | -23.4 % |
Return on Assets (ttm) | -10.8 % |
Return on Equity (ttm) | -79.8 % |
Qtrly Rev. Growth | -63.8 % |
Gross Profit (p.s.) | 10.65 |
Sales Per Share | 78.73 |
EBITDA (p.s.) | -7.12 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -4 (M) |
Levered Free Cash Flow | 8 (M) |
PE Ratio | -0.21 |
PEG Ratio | 0 |
Price to Book value | 0.23 |
Price to Sales | 0.06 |
Price to Cash Flow | -0.87 |
Dividend | 2.26 |
Forward Dividend | 0 |
Dividend Yield | 46.8% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |